| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.045 | 0.3 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | 0.17 | 0.3 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | -0.031 | 0.3 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.3 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.3 |